報價延遲最少15分鐘:2025/07/04 19:31 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
79.98 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
4.29/5.05
|
|
企業價值
4.98B
|
| 資產負債 |
|
每股賬面淨值
37.27
|
| 現金流量 |
|
現金流量率
0.06
|
| 損益表 |
|
收益
1.14B
|
|
每股收益
22.89
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/04 19:31 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets. |